Metabolic dysfunction-associated steatotic liver disease, also known as MASLD or fatty liver disease, is a chronic condition where fat builds up in the liver. This can lead to inflammation, fibrosis, and in some cases, serious liver complications like cirrhosis or liver failure. MASLD often occurs alongside obesity, diabetes, or other metabolic disorders, making disease management more challenging.
Our ongoing steatotic liver disease research studies focus on finding better treatments and strategies to manage MASLD effectively. By joining these studies, participants help test investigational treatment of fatty liver disease, as well as lifestyle and dietary approaches designed to improve liver health. Participation not only contributes to scientific understanding but also provides access to innovative care options that may enhance quality of life.
